Events & Presentations

Mapi Pharma’s late-breaker abstract submission, showing the results of our Phase II clinical trial, will be presented on October 27th, between 15.30-17.00, at the poster session at ECTRIMS-ACTRIMS Conferences in Paris, held on October 25-28, 2017


Mapi Pharma Corporate Overview


Mapi Pharma Presentation for the International Joint Israel-Greek-Italian Neuroimmunological Meeting | Crete, June 11-14, 2015


Mapi Pharma Poster for the 2015 ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) Congress | Barcelona, October 7-10, 2015

Poster Abstract